BSX
Price
$105.41
Change
+$0.49 (+0.47%)
Updated
Aug 1 closing price
Capitalization
100.1B
80 days until earnings call
DXCM
Price
$79.28
Change
-$1.49 (-1.84%)
Updated
Aug 1 closing price
Capitalization
53.47B
81 days until earnings call
Interact to see
Advertisement

BSX vs DXCM

Header iconBSX vs DXCM Comparison
Open Charts BSX vs DXCMBanner chart's image
Boston Scientific
Price$105.41
Change+$0.49 (+0.47%)
Volume$6.34M
Capitalization100.1B
DexCom
Price$79.28
Change-$1.49 (-1.84%)
Volume$5.24M
Capitalization53.47B
BSX vs DXCM Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. DXCM commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and DXCM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2025
Stock price -- (BSX: $105.41 vs. DXCM: $79.28)
Brand notoriety: BSX: Notable vs. DXCM: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 81% vs. DXCM: 164%
Market capitalization -- BSX: $100.1B vs. DXCM: $53.47B
BSX [@Medical Specialties] is valued at $100.1B. DXCM’s [@Medical Specialties] market capitalization is $53.47B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileDXCM’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • DXCM’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 6 TA indicator(s) are bullish while DXCM’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 6 bullish, 3 bearish.
  • DXCM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BSX is a better buy in the short-term than DXCM.

Price Growth

BSX (@Medical Specialties) experienced а -0.69% price change this week, while DXCM (@Medical Specialties) price change was -10.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.56%. For the same industry, the average monthly price growth was -2.26%, and the average quarterly price growth was -4.37%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

DXCM is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (-2.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than DXCM($53.5B). DXCM has higher P/E ratio than BSX: DXCM (106.11) vs BSX (63.64). BSX YTD gains are higher at: 18.014 vs. DXCM (1.942). BSX has higher annual earnings (EBITDA): 3.45B vs. DXCM (917M). DXCM has more cash in the bank: 2.72B vs. BSX (865M). DXCM has less debt than BSX: DXCM (2.59B) vs BSX (9.49B). BSX has higher revenues than DXCM: BSX (14.2B) vs DXCM (3.62B).
BSXDXCMBSX / DXCM
Capitalization100B53.5B187%
EBITDA3.45B917M376%
Gain YTD18.0141.942928%
P/E Ratio63.64106.1160%
Revenue14.2B3.62B392%
Total Cash865M2.72B32%
Total Debt9.49B2.59B366%
FUNDAMENTALS RATINGS
BSX vs DXCM: Fundamental Ratings
BSX
DXCM
OUTLOOK RATING
1..100
8014
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
4100
SMR RATING
1..100
6940
PRICE GROWTH RATING
1..100
3859
P/E GROWTH RATING
1..100
4524
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (82) in the Medical Specialties industry is in the same range as BSX (84). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for DXCM (100). This means that BSX’s stock grew significantly faster than DXCM’s over the last 12 months.

DXCM's SMR Rating (40) in the Medical Specialties industry is in the same range as BSX (69). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (38) in the Medical Specialties industry is in the same range as DXCM (59). This means that BSX’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's P/E Growth Rating (24) in the Medical Specialties industry is in the same range as BSX (45). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXDXCM
RSI
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
56%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
45%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSKH53.140.34
+0.64%
GSK PLC ADRHEDGED GSKH
IQI9.320.03
+0.32%
INVESCO QUALITY Municipal SECURITIES
FRNW16.63-0.07
-0.44%
Fidelity Clean Energy ETF
GOOY12.73-0.18
-1.39%
YieldMax GOOGL Option Income Stgy ETF
KBWB71.78-1.74
-2.37%
Invesco KBW Bank ETF

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.47%
ISRG - BSX
71%
Closely correlated
N/A
SYK - BSX
67%
Closely correlated
-3.80%
MMSI - BSX
56%
Loosely correlated
-0.09%
ALC - BSX
49%
Loosely correlated
+0.37%
EW - BSX
48%
Loosely correlated
+0.03%
More